Cargando…

Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma

Epidemiological studies showed that obesity and its related non-alcoholic fatty liver disease (NAFLD) promote hepatocellular carcinoma (HCC) development. We aimed to uncover the genetic alterations of NAFLD-HCC using whole-exome sequencing. We compared HCC development in genetically obese mice and d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, J, Tsoi, H, Liang, Q, Chu, E S H, Liu, D, Yu, A C-S, Chan, T F, Li, X, Sung, J J Y, Wong, V W S, Yu, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153568/ https://www.ncbi.nlm.nih.gov/pubmed/27132506 http://dx.doi.org/10.1038/onc.2016.162

Ejemplares similares

Oncogenic PIK3CA Mutation and Dysregulation in Human Salivary Duct Carcinoma
por: Qiu, Wanglong, et al.
Publicado: (2014)

Endogenous Retrotransposition Activates Oncogenic Pathways in Hepatocellular Carcinoma
por: Shukla, Ruchi, et al.
Publicado: (2013)

Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma
por: Tian, Lu, et al.
Publicado: (2021)

PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner
por: Kam, Charles Shing, et al.
Publicado: (2023)

The GNAQ T96S Mutation Affects Cell Signaling and Enhances the Oncogenic Properties of Hepatocellular Carcinoma
por: Choi, Eugene, et al.
Publicado: (2021)

Identification of the Novel Oncogenic Role of SAAL1 and Its Therapeutic Potential in Hepatocellular Carcinoma
por: Chu, Pei-Yi, et al.
Publicado: (2020)

Comparing gene expression in deep infiltrating endometriosis with adenomyosis uteri: evidence for dysregulation of oncogene pathways
por: Marshall, A., et al.
Publicado: (2023)

Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling
por: Liang, Jessie Qiaoyi, et al.
Publicado: (2018)

Oncogenic signaling pathway dysregulation landscape reveals the role of pathways at multiple omics levels in pan-cancer
por: Wang, Na, et al.
Publicado: (2022)

Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma
por: Wang, Fang, et al.
Publicado: (2021)

Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice
por: Chen, H, et al.
Publicado: (2017)

Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
por: Du, Danyu, et al.
Publicado: (2022)

Pro-oncogenic potential of NM23-H2 in hepatocellular carcinoma
por: Lee, Mi-Jin, et al.
Publicado: (2012)

Benchmarking pathway interaction network for colorectal cancer to identify dysregulated pathways
por: Wang, Q., et al.
Publicado: (2017)

α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway
por: Zhao, Y, et al.
Publicado: (2017)

Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways
por: Lu, Haofeng, et al.
Publicado: (2022)

Retraction Note: α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway
por: Zhao, Y., et al.
Publicado: (2020)

Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma
por: Ge, Zhouhong, et al.
Publicado: (2021)

Identification of potentially oncogenic alterations from tumor-only samples reveals Fanconi anemia pathway mutations in bladder carcinomas
por: Madubata, Chioma J, et al.
Publicado: (2017)

Oncogenic RIT1 mutations in lung adenocarcinoma
por: Berger, A H, et al.
Publicado: (2014)

Molecular subtyping and IMScore based on immune-related pathways, oncogenic pathways, and DNA damage repair pathways for guiding immunotherapy in hepatocellular carcinoma patients
por: Yu, Zeyan, et al.
Publicado: (2022)

Epigenetic Dysregulation in Laryngeal Squamous Cell Carcinoma
por: Wong, Thian-Sze, et al.
Publicado: (2012)

Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma
por: Bengochea, A, et al.
Publicado: (2008)

Role of Oncogenic Pathways on the Cancer Immunosuppressive Microenvironment and Its Clinical Implications in Hepatocellular Carcinoma
por: Nishida, Naoshi
Publicado: (2021)

MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma
por: You, Yu, et al.
Publicado: (2016)

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma
por: Jin, Shaowen, et al.
Publicado: (2014)

Usp5 functions as an oncogene for stimulating tumorigenesis in hepatocellular carcinoma
por: Liu, Yi, et al.
Publicado: (2017)

Oncogene mutational profile in nasopharyngeal carcinoma
por: Zhang, Zi-Chen, et al.
Publicado: (2014)

NOL12 as an Oncogenic Biomarker Promotes Hepatocellular Carcinoma Growth and Metastasis
por: Huang, Jianfeng, et al.
Publicado: (2022)

miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression
por: Chu, Rui, et al.
Publicado: (2014)

Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability
por: Thomas, Daniel, et al.
Publicado: (2023)

Sex differences in oncogenic mutational processes
por: Li, Constance H., et al.
Publicado: (2020)

The oncogenic role of hepatitis delta virus in hepatocellular carcinoma
por: Puigvehí, Marc, et al.
Publicado: (2019)

The Oncogenic and Diagnostic Potential of Stanniocalcin 2 in Hepatocellular Carcinoma
por: Wu, Zhixian, et al.
Publicado: (2022)

Low Incidence of Point Mutation of c‐Ki‐ras and N‐ras Oncogenes in Human Hepatocellular Carcinoma
por: Tsuda, Hitoshi, et al.
Publicado: (1989)

Splicing factor PRPF6 upregulates oncogenic androgen receptor signaling pathway in hepatocellular carcinoma
por: Song, Huijuan, et al.
Publicado: (2020)

ahctf1 and kras mutations combine to amplify oncogenic stress and restrict liver overgrowth in a zebrafish model of hepatocellular carcinoma
por: Morgan, Kimberly J, et al.
Publicado: (2023)

Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma
por: Zhang, Jian-Wei, et al.
Publicado: (2015)

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ckvtp7hmg2hvsmajjp36ifduai